Trinity Care Solutions Recalls Vancomycin Due to Sterility Concerns
Trinity Care Solutions is recalling 14 units of Vancomycin 1.25 gm/250 mL due to lack of assurance of sterility identified during an FDA inspection.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in a parenteral product, which poses a significant risk of serious injury or death from infection, meeting the criteria for a Severe rating.
Plain-English summary
Trinity Care Solutions, operating as Franck's Lab Inc, is recalling 14 units of Vancomycin 1.25 gm/250 mL 0.9%NS. The product is labeled for parenteral use only and was distributed in Florida. The specific recall number is D-1473-2014.
The recall was initiated due to a lack of assurance of sterility. This decision follows concerns regarding quality control procedures observed during a recent FDA inspection. The agency has classified this recall as Class II.
All lots of sterile products compounded by the pharmacy within their expiry dates are subject to this recall. Patients and healthcare providers should stop using the affected product and contact their pharmacist or healthcare provider for further instructions.
The recalled product
- Product
- Vancomycin 1.25 gm/250 mL 0.9%NS,Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29140, Discard After 05/23/14
- Manufacturer
- Franck's Lab Inc dba Trinity Care Solutions
- Category
- Drug — Antibiotic
- Affected units
- 14
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Rx # 29140
- Exp 05/23/14
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 30 recalled by Franck's Lab Inc dba Trinity Care Solutions under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 30 products in this recall →Related recalls
Same manufacturer · Franck's Lab Inc dba Trinity Care Solutions
See all →- SevereTrinity Care Solutions Recalls ANA Kit Due to Sterility Concerns
FDA (Drugs) · 2014-07-30
- SevereTrinity Care Solutions Recalls Compounded Cubicin Due to Sterility Concerns
FDA (Drugs) · 2014-07-30
- SevereTrinity Care Solutions Recalls Desferal Sterile Compounds Due to Sterility Concerns
FDA (Drugs) · 2014-07-30
- SevereTrinity Care Solutions Recalls Compounded Cubicin Due to Sterility Concerns
FDA (Drugs) · 2014-07-30
- SevereTrinity Care Solutions Recalls Unasyn Due to Sterility Concerns
FDA (Drugs) · 2014-07-30
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereWalter's Pharmacy Recalls Vancomycin Solution Due to Sterility Concerns
FDA (Drugs) · 2016-04-06
- HighVancomycin Ophthalmic Solution Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2016-06-15
- SevereVancomycin Recall Due to Sterility Concerns at Compounding Pharmacy
FDA (Drugs) · 2013-07-10
- HighVancomycin Ophthalmic Solutions Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2023-02-01
- SevereVancomycin Ophthalmic Solution Recalled Due to Sterility Concerns
FDA (Drugs) · 2022-03-23
- SevereVancomycin Eye Drops Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2014-03-12